Karis Bio
PrivateLast Round
Series B
Dec 1, 2024
Total Funding Raised
$17.18M
Company Overview
Karis Bio is a biotechnology company that develops regenerative cell therapies using induced pluripotent stem cell (iPSC) technology to treat cardiovascular diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Karis Bio Comparables
Compare Karis Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cuorips Inc. | 77% | |
| IPS HEART | 75% | |
| Bayer AG | 69% | |
Karis Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Dec 1, 2024 | ||||
| Series A | May 1, 2021 | ||||
| Angel | Dec 1, 2020 |
Karis Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Premier Partners | Series B, Series A |
| Devsisters Ventures | Series B, Series A |
| Korea Development Bank | Series B, Series A |
| Korea Venture Investment Corporation | Series B |
| AJU IB Investment | Series B, Series A |
Karis Bio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Karis Bio's valuation, stock price, and market status.